Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06366256 · ClinicalTrials.gov registry record · NA

Simplified Ultrasound Feedback for Speech Remediation

A NA study of Speech Sound Disorder, sponsored by University of Cincinnati.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT06366256: Recruiting NA study of Speech Sound Disorder, sponsored by University of Cincinnati.

NCT06366256 is a NA study of Speech Sound Disorder that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 24 participants, below the 88-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06366256, a NA study of Speech Sound Disorder, is actively recruiting participants, sponsored by University of Cincinnati.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

Recent research in motor control shows that people learn new movements best when they receive feedback external to the body. Traditional ultrasound speech therapy works well for many children, but involves teaching children to focus on their internal tongue movements. The goal of the study is to test whether ultrasound biofeedback delivered without showing children a display of their tongue movements will be effective as a treatment for residual speech sound disorders in children. We focus on children who have trouble producing the sound "r" as in "rabbit". The first aim is to develop a fast reliable system to track movements of different parts of the tongue using ultrasound and to identify which combinations of movements will produce a good "r" and which do not. The second aim is to develop a motivational game in which children receive feedback on the success of their tongue movements by what happens to an animated character on a screen. This developed version of ultrasound feedback therapy will be compared to the traditional version of ultrasound feedback therapy to determine how the two approaches can best be utilized in the clinic.

Conditions Studied

Interventions

  • BEHAVIORAL Traditional ultrasound biofeedback
  • BEHAVIORAL Simplified ultrasound biofeedback

Study Locations (1)

Ohio

  • University of Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2023-10-24
Est. Completion 2025-08
Phase NA
University of Cincinnati

245 total trials

What NCT06366256 shows while recruiting

NCT06366256 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 88-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Speech Sound Disorder appearing as the primary indexed condition, and to 2 interventions - of which Traditional ultrasound biofeedback is the first listed.

NCT06366256 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06366256 about?

NCT06366256 is a clinical study titled "Simplified Ultrasound Feedback for Speech Remediation". Recent research in motor control shows that people learn new movements best when they receive feedback external to the body. Traditional ultrasound speech therapy works well for many children, but involves teaching children to focus on their internal tongue movements. The goal of the study is to tes...

What is the current status of trial NCT06366256?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2023-10-24. Estimated completion is 2025-08.

What conditions does trial NCT06366256 study?

This clinical trial studies the following conditions: Speech Sound Disorder.

What interventions are being tested in trial NCT06366256?

The interventions under investigation include: Traditional ultrasound biofeedback (BEHAVIORAL), Simplified ultrasound biofeedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT06366256?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06366256 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Speech Sound Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06366256's enrollment target sits among peer trials

24 13th of 15 higher than 2 of 15 other Speech Sound Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Speech Sound Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06366256, the US trial registry maintained by the National Library of Medicine. NCT06366256 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.